|Role of Acid and weakly acidic reflux in gastroesophageal reflux disease off proton pump inhibitor therapy.|
|Jump to Full Text|
|PMID: 22837877 Owner: NLM Status: PubMed-not-MEDLINE|
|BACKGROUND/AIMS: Available data about reflux patterns and symptom determinants in the gastroesophageal reflux disease (GERD) subtypes off proton pump inhibitor (PPI) therapy are lacking. We aimed to evaluate reflux patterns and determinants of symptom perception in patients with GERD off PPI therapy by impedance-pH monitoring.
METHODS: We retrospectively reviewed the impedance-pH data in patients diagnosed as GERD based on results of impedance-pH monitoring, endoscopy and/or typical symptoms. The characteristics of acid and weakly acidic reflux were evaluated. Symptomatic and asymptomatic reflux were compared according to GERD subtypes and individual symptoms.
RESULTS: Forty-two patients (22 males, mean age 46 years) were diagnosed as GERD (17 erosive reflux disease, 9 pH(+) non-erosive reflux disease [NERD], 9 hypersensitive esophagus and 7 symptomatic NERD). A total of 1,725 reflux episodes were detected (855 acid [50%], 857 weakly acidic [50%] and 13 weakly alkaline reflux [< 1%]). Acid reflux was more frequently symptomatic and bolus clearance was longer compared with weakly acidic reflux. In terms of globus, weakly acidic reflux was more symptomatic. Symptomatic reflux was more frequently acid and mixed reflux; these associations were more pronounced in erosive reflux disease and symptomatic NERD. The perception of regurgitation was related to acid reflux, while that of globus was more related to weakly acidic reflux.
CONCLUSIONS: In patients not taking PPI, acid reflux was more frequently symptomatic and had longer bolus clearance. Symptomatic reflux was more frequently acid and mixed type; however, weakly acidic reflux was associated more with globus. These data suggest a role for impedance-pH data in the evaluation of globus.
|Hea Jung Sung; Yu Kyung Cho; Sung Jin Moon; Jin Su Kim; Chul Hyun Lim; Jae Myung Park; In Seok Lee; Sang Woo Kim; Myung-Gye Choi|
Related Documents :
|12150277 - Synthesis of 2-[18f]fluoro-l-tyrosine via regiospecific fluoro-de-stannylation.
3100797 - Folate analogues. 25. synthesis and biological evaluation of n10-propargylfolic acid an...
14625007 - Estrano[17,16-e]pyrimidine-peptide conjugates.
16995657 - Controlled synthesis of (s,s)-2,7-diaminosuberic acid: a method for regioselective cons...
564947 - Plasma amino acid concentrations in umbilical cord vein and artery of newborn infants a...
1595587 - Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic ...
|Type: Journal Article Date: 2012-07-10|
|Title: Journal of neurogastroenterology and motility Volume: 18 ISSN: 2093-0887 ISO Abbreviation: J Neurogastroenterol Motil Publication Date: 2012 Jul|
|Created Date: 2012-07-27 Completed Date: 2012-10-02 Revised Date: 2013-05-30|
Medline Journal Info:
|Nlm Unique ID: 101530189 Medline TA: J Neurogastroenterol Motil Country: Korea (South)|
|Languages: eng Pagination: 291-7 Citation Subset: -|
|Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): J Neurogastroenterol Motil
Journal ID (iso-abbrev): J Neurogastroenterol Motil
Journal ID (publisher-id): JNM
Publisher: Korean Society of Neurogastroenterology and Motility
© 2012 The Korean Society of Neurogastroenterology and Motility
Received Day: 23 Month: 2 Year: 2012
Revision Received Day: 28 Month: 4 Year: 2012
Accepted Day: 30 Month: 4 Year: 2012
Print publication date: Month: 7 Year: 2012
Electronic publication date: Day: 10 Month: 7 Year: 2012
Volume: 18 Issue: 3
First Page: 291 Last Page: 297
PubMed Id: 22837877
|Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy|
|Hea Jung SungA1|
|Yu Kyung ChoA1|
|Sung Jin MoonA1|
|Jin Su KimA1|
|Chul Hyun LimA1|
|Jae Myung ParkA1|
|In Seok LeeA1|
|Sang Woo KimA1|
|Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.
Correspondence: Yu Kyung Cho, MD. Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary's Hospital, Banpo-daero 222, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-2044, Fax: +82-2-2258-2055, email@example.com
Not all reflux episodes occurring in patients with gastroesophageal reflux disease (GERD) are accompanied by reflux symptoms. The reason that some reflux episodes evoke symptoms and the nature of the determinants of gastroesophageal reflux (GER) perception remain unclear. In patients on acid suppression therapy, the high proximal extent of refluxate and gas were important factors associated with reflux perception.1,2 Weakly acidic reflux underlies the majority of reflux episodes in patients with GERD on proton pump inhibitor (PPI) therapy and is considered the main cause of reflux symptoms occurring despite PPI therapy.3,4
Studies demonstrate that in patients with GERD not taking a PPI, the majority of symptomatic reflux episodes are acidic, and approximately one third of symptomatic reflux episodes are weakly acidic.5 Weakly acidic reflux is responsible for only a minor portion of symptomatic reflux episodes in patients off medication, highlighting their relatively minor role in symptom causation. However, acid reflux alone does not account for all of the symptoms reported by GERD patients.6 The diagnostic gain resulting from impedance testing for detecting weakly acidic reflux in patients off PPI therapy may be higher with atypical GERD symptoms.7-10 Furthermore, existing data on the pathophysiology of NERD suggest that abnormal esophageal acid exposure cannot be the sole cause of these symptoms. Combined pH and multichannel intraluminal impedance (MII) monitoring allows characterization of reflux episodes as acid, weakly acidic, or weakly alkaline as well as assessment of their proximal extent within the esophagus and composition. Use of combined pH-MII monitoring is bringing into focus the potential role of weakly acidic and weakly alkaline reflux in GERD and in production of symptoms associated with reflux episodes. The aim of this study was to characterize reflux episodes and determinants of symptom perception in patients not taking PPI according to GERD subtypes and individual symptoms using impedance-pH monitoring.
Approval for this retrospective study was obtained from the Catholic University of Korea Institutional Review Boards. Between January 2009 and March 2011, 24-hour ambulatory combined MII-pH monitoring was carried out in consecutive patients for evaluation of GERD at Seoul St. Mary's hospital, a tertiary university hospital. All patients had at least one typical reflux symptom (heartburn and acid regurgitation) or atypical symptoms (globus or chronic cough) that occurred more than twice per week. All patients underwent endoscopy within 2 months before MII-pH monitoring. Of these, 42 (22 males, mean age 46 ± 12 years) who were diagnosed with GERD by endoscopy and combined MII-pH were enrolled in this study. They were classified as (1) erosive reflux disease (ERD); (2) pH(+) non-erosive reflux disease (NERD) with normal endoscopy and abnormal distal esophageal acid exposure; (3) hypersensitive esophagus with normal endoscopy, normal distal esophageal acid exposure, and positive symptom association for either acid or nonacid reflux; and (4) symptomatic NERD with normal endoscopy, normal distal esophageal acid exposure, negative symptom association, typical GERD symptoms and positive PPI test. Exclusion criteria were prior fundoplication, history of thoracic, esophageal, gastric surgery, and primary or secondary severe esophageal motility disorders.
Before pH monitoring, symptom assessment was performed using a reflux-symptoms questionnaire. This questionnaire included typical symptoms (heartburn and acid regurgitation), epigastric pain, epigastric soreness and atypical symptoms (eg, globus, hoarseness, chronic cough and chest pain). Symptom severity was evaluated using the 5-point Likert scale consisting of 'none', 'mild' (an occasional symptom that can be ignored, does not influence daily routine or sleep), 'moderate' (symptom cannot be ignored and/or occasionally influences daily routine or sleep), 'severe' (symptom presents more frequently during the day or night and/or regularly influences daily routine or sleep) and 'very severe' (a constant symptom and/or markedly influences daily routine or sleep). Symptom frequency (2-3 times per month, 1-2 times per week, 3-4 times per week and 5-6 times per week and daily) and most bothersome symptom were also checked. Patients whose symptom severity was from moderate to severe, occuring more than 2 episodes per week were included. Globus was defined as a sense of lump, a retained food bolus, or tightness in the throat, which was non-painful, frequently improved with eating, commonly was episodic, and was unassociated with dysphagia or odynophagia.11,12 Chronic cough was defined as cough which lasted more than 3 weeks.
Only 30 (18 males, mean age 50 ± 16 years) patients (71%) who complained of any type of reflux symptom during MII were selected for further analysis of reflux characteristics (acid/weakly acidic/weakly alkaline), and reflux-symptom association. Twelve patients did not complain of any symptoms during the 24-hour recording.
The study was carried out on an outpatient basis after at least 8 hours of fasting. PPI and all other drugs potentially affecting gastrointestinal motility and secretion were discontinued at least 2 weeks prior to the study. Esophageal impedance-pH monitoring was performed using a Sleuth® Multichannel Intraluminal Impedance ambulatory system (Sandhill Scientific, Inc., Highlands Ranch, CO, USA). The 6-channel impedance catheter-pH catheter was passed transnasally under topical anesthesia and attached 5 cm above the manometrically localized lower esophageal sphincter (LES) to record pH at 5 cm and impedance at 3, 5, 7, 9, 15 and 17 cm proximal to the LES. The pH and impedance signals were stored in a data-collection device. Patients were encouraged to maintain normal activity, sleep schedules and usual meals at their normal times. They were asked to record symptoms during the study period. Data from the impedance channels and the pH electrodes were stored on a portable data recorder (Sleuth; Sandhill Scientific, Inc., Highlands Ranch, CO, USA). At the end of the 24-hour recording period, data were downloaded onto a computer and analyzed using dedicated software (BioViewanalysis®; Sandhill Scientific, Inc.).
Recorded pH data were used to classify reflux episodes as acid, weakly acidic or weakly alkaline. Definitions were as follows: (1) acid reflux: refluxed gastric juice with a pH < 4, which can either reduce the pH of the esophagus to < 4 or occur when the esophagus pH is already < 4; (2) weakly acidic reflux: reflux events that result in an esophageal pH between 4 and 7; and (3) weakly alkaline reflux: reflux episodes during which nadir esophageal pH does not drop below 7.
Liquid reflux was defined as a retrograde 50% drop in impedance starting distally (at the level of the LES) and propagating to at least the next two proximal impedance measuring segments. Gas reflux was defined as a rapid (3 kΩ/s) increase in impedance > 5,000 Ω, occurring simultaneously in at least 2 esophageal impedance measuring segments, in the absence of swallowing. Mixed liquid-gas reflux was defined as gas reflux occurring immediately before or during a liquid reflux.
Total 24-hour esophageal acid exposure (%) was defined as the total time at pH below 4 divided by the time of monitoring. Total distal esophageal acid exposure less than 4.2% over 24 hours was considered normal. The symptom index (SI) and symptom-association probability (SAP) were calculated according to the formula described previously. SI was defined as the number of symptoms associated with reflux divided by the total number of symptoms. SAP was calculated as the probability that the observed distribution could have occurred by chance. SI and SAP were considered to be positive at ≥ 50% and ≥ 95%, respectively.
All reflux events were analyzed in both the upright and supine positions. Each individual reflux event was analyzed separately and classified as symptomatic or not. Reflux events were considered symptomatic if their onset occurred within a 2 minute time window before the patient activated an event marker. For example, if the onset of globus or throat discomfort was within 2 minutes after onset of reflux episodes, we considered it as a symptomatic reflux which provoked throat discomfort. For each reflux event, the following variables were determined: body position, reflux composition (liquid or mixed liquid-gas), chemical composition (acid, weakly acidic or weakly alkaline) and proximal reflux (reflux reaching the 15 cm impedance site). Median reflux bolus clearance time (BCT) of refluxate was defined as the time, in seconds, from the 50% drop in impedance until impedance again recovered to above this point (determined 5 cm above the LES).
All data were collected retrospectively. Quantitative and qualitative data are given as, respectively, median (interquartile range) and number (percentage). Comparisons between symptomatic and asymptomatic reflux episodes were performed on a per-subject basis using the Wilcoxon signed-rank tests. Comparison of the characteristics of reflux episodes preceding each symptom was performed using Mann-Whitney tests and χ2 tests or Fisher's exact tests, when appropriate. A P-value < 0.05 was considered statistically significant.
Forty-two patients (22 males, mean age 46 years old) were enrolled. Patients were classified as 17 ERD (8 males, 50 ± 17 years old), 9 pH(+) NERD (6 males, 46 ± 14 years old), 9 hypersensitive esophagus (4 males, 58 ± 11 years old) and 7 symptomatic NERD (4 males, 36 ± 13 years old). Fourteen patients complained predominantly of typical symptoms, and 26 of predominantly atypical symptoms. During the monitoring period, 30 patients (71%) reported at least 1 episode of symptom such as heartburn, regurgitation, globus or belching (11 ERD, 6 pH[+] NERD, 9 hypersensitive esophagus and 4 symptomatic NERD) and were included for further analysis of reflux-symptom association.
A total of 1,725 reflux episodes occurred during pH monitoring, including 855 acid (49.6%), 857 weakly acidic (49.7%) and 13 weakly alkaline reflux (0.8%). The majority of reflux episodes occurred while patients were in the upright position. More reflux episodes reached the proximal esophagus (73% vs 55%), and median bolus clearance time measured at 5 cm from LES was longer (11.6 [5.7-22.6] vs 9.4 [3.9-20.5] seconds) in acid reflux than in weakly acidic reflux. More reflux episodes were symptomatic in acid reflux (P < 0.01); however, in the symptomatic reflux episodes, globus associated reflux was more common in weakly acid reflux than acid reflux (20% vs 6%, P < 0.05) (Table 1).
Acidity, nadir pH, and time of refluxate bolus clearance did not differ between ERD and NERD patients. The total number of mixed reflux was higher in ERD patients than in patients with NERD (61% vs 53%); however, the proportion of mixed reflux to total reflux episodes was various among patients with ERD or NERD (Table 2).
We analyzed a total of 1,074 reflux episodes in 30 patients. Of these, 110 (10%) reflux episodes were symptomatic, and 964 asymptomatic. Median (25-75th) number of symptomatic reflux episodes per a patient was 4 (2-9) (range 1-28). Compared with asymptomatic reflux episodes, symptomatic reflux episodes had a higher proportion of mixed reflux (67% vs 56%, P < 0.01) and acid reflux (67% vs 46%, P < 0.01), as well as a greater pH drop (Table 3).
Characteristics of reflux episodes according to GERD subtype are shown in Figure. In ERD and symptomatic NERD, symptomatic reflux episodes were more frequently preceded by acid reflux episodes and a larger pH drop compared with asymptomatic reflux episodes. However, there were no definite symptom-related factors in pH(+) NERD or hypersensitive esophagus.
The 110 symptomatic reflux episodes consisted of 19 episodes of regurgitation, 12 of globus and 79 of belching (Table 4). Reflux episodes associated with regurgitation were more frequently mixed reflux (83%) and acidic (89%), more frequently reached the proximal esophagus (83%), and had a greater pH drop (3.4 ± 1.4), whereas globus was more associated with weakly acidic reflux (58%). The proportions of acid reflux episodes, mixed reflux episodes, and pH drop in reflux associated with belching were between regurgitation and globus.
We investigated the characteristics of reflux episodes and reflux-symptom associations in patients with GERD not taking PPI. In this study, the proportion of acid and weakly acidic reflux in patients with GERD was almost identical (each 49.6%). Weakly alkaline reflux accounted for < 1% of all reflux episodes. Patients whose symptoms were predominantly atypical and who were documented as ERD or pH(+) NERD were included, which may explain the lower proportion of acid reflux and higher proportion of weakly acidic reflux compared with a systematic review (63% [95% CI, 59-67] of acid reflux and 37% [95% CI, 33-41] weakly acidic reflux). The proportion of acid and weakly acidic reflux episodes did not differ between ERD and NERD groups, likely because all ERD patients were diagnosed with mild esophagitis (Los Angeles classification A).
The characteristics of acid reflux differed from those of weakly acidic reflux. In acid reflux, proximal reflux events were more frequent, and mixed liquid and gas reflux was more common. Additionally, bolus clearance time from the distal esophagus was longer. The esophageal mucosal injury caused by acid reflux was related to acidity and a longer bolus clearance time. These data suggest that acid reflux is more responsible for symptom generation and esophageal mucosal injury. Symptomatic reflux was more commonly related to acid reflux. Fifteen percent of acid reflux, but only 8% of weakly acidic reflux, was related to symptoms. However, globus was more commonly associated with weakly acidic reflux. Another study also suggested a relationship between atypical symptoms and weakly acidic reflux.13 This result also supports the role of impedance-pH monitoring in the evaluation of globus.
Sixty-seven percent of reflux symptom episodes were associated with acid reflux episodes; 33% of symptomatic reflux episodes were associated with weakly acidic or weakly alkaline reflux. This suggests that determinants of symptoms differ among GERD subtypes. Although the group population was too small to draw the conclusion in this study, acid reflux episodes and gas-containing mixed reflux episodes played a major role in eliciting symptoms in ERD and symptomatic NERD but were not responsible for symptom perception in pH(+) NERD or hypersensitive esophagus. Thus, PPI responsiveness will likely be better in patients with ERD and symptomatic NERD than in those with hypersensitive esophagus. NERD patients are a heterogeneous group. All symptomatic NERD defined in this study responded to PPI therapy and were not classified as functional heartburn according to the Rome III criteria.
Existing data on the pathophysiology of NERD suggests that abnormal esophageal acid exposure cannot be the sole cause of symptoms. These findings support the concept that reflux volume-induced distension may be responsible for these symptoms. Emerenziani et al14 reported that in NERD patients, the presence of gas in the refluxate significantly enhanced the probability of reflux perception and emphasize the role of gas as an enhancer of symptoms. One of the mechanisms by which weakly acidic or weakly alkaline reflux is believed to generate esophageal symptoms is mechanical stimulation; large volumes of refluxate can trigger heartburn irrespective of its acidity.
Typical symptoms were more related to acidic and mixed reflux, whereas globus was associated with weakly acidic and gascontaining reflux. There are few data regarding the factors involved in generation of atypical symptoms, although these have been supposed to be related to non-acid reflux. Impedance-pH studies will be valuable for assessing globus. Our findings explain the lower responsiveness of PPI to extraesophageal symptoms. Belching was a common complaint during pH monitoring. Belching is a physiological phenomenon and is defined as GER of gas. Belching and reflux thus occur through the same mechanism. With impedance monitoring, transport of gas and liquid in the esophagus can be monitored, and use of this technique has shown that most reflux episodes indeed consist of both a liquid and a gaseous component. As mentioned above, GER of gas distends the esophageal body, and this distention can trigger heartburn and chest pain.15 Indeed, some patients with GERD reported the sensation of heartburn during reflux episodes containing only gas.16 The impedance patterns of belching in patients in this study had different characteristics from the definition of belching. Belching was not always gas-containing reflux. Therefore, it cannot be classified as either supragastric or gastric belching. One of the explanations is that patients' expression of belching in this study may be different from criteria of other studies. The impedance characteristics of belching were between those of regurgitation and globus, suggesting that PPI may be an effective initial treatment for belching accompanied by GER symptoms.
In summary, in patients with GERD who were not taking PPI, acid reflux represented 50% of all reflux. Acid reflux was more frequently symptomatic and had a longer bolus clearance time. Symptomatic reflux was more frequently of acidic and mixed type, especially in patients with ERD. However, weakly acidic reflux was more related to globus. Thus, our data suggest a role for impedance-pH assessment in the evaluation of globus.
Financial support: None.
Conflicts of interest: None.
|1.||Zerbib F,Duriez A,Roman S,Capdepont M,Mion F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitorsGutYear: 20085715616017951358|
|2.||Tutuian R,Vela MF,Hill EG,Mainie I,Agrawal A,Castell DO. Characteristics of symptomatic reflux episodes on acid suppressive therapyAm J GastroenterolYear: 20081031090109618445095|
|3.||Mainie I,Tutuian R,Shay S,et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre studyGutYear: 2006551398140216556669|
|4.||Zerbib F,Roman S,Ropert A,et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapyAm J GastroenterolYear: 20061011956196316848801|
|5.||Boeckxstaens GE,Smout A. Systematic review: role of acid, weakly acidic and weaklyalkaline reflux in gastro-esophageal reflux diseaseAliment Pharmacol TherYear: 20103233434320491749|
|6.||Koek GH,Tack J,Sifrim D,Lerut T,Janssens J. The role of acid and duodenal gastroesophageal reflux in symptomatic GERDAm J GastroenterolYear: 2001962033204011467629|
|7.||Sifrim D,Dupont L,Blondeau K,Zhang X,Tack J,Janssens J. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoringGutYear: 20055444945415753524|
|8.||Bajbouj M,Becker V,Neuber M,Schmid RM,Meining A. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptomsDigestionYear: 20077622322818174685|
|9.||Anandasabapathy S,Jaffin BW. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapyAnn Otol Rhinol LaryngolYear: 200611556357016944654|
|10.||Blondeau K,Dupont LJ,Mertens V,Tack J,Sifrim D. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic coughAliment Pharmacol TherYear: 20072572373217311606|
|11.||Galmiche JP,Clouse RE,Bálint A,et al. Functional esophageal disordersGastroenterologyYear: 20061301459146516678559|
|12.||Rakshit R,de Caestecker J. Globus: are we any nearer to understanding it?Am J GastroenterolYear: 200910429930119190607|
|13.||Savarino E,Marabotto E,Zentilin P,et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux diseaseDig Liver DisYear: 20114354254721376679|
|14.||Emerenziani S,Sifrim D,Habib FI,et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagusGutYear: 20085744344717766596|
|15.||Kahrilas P J,Dodds WJ,Hogan WJ. Dysfunction of the belch reflex. A cause of incapacitating chest painGastroenterologyYear: 1987938188223623025|
|16.||Bredenoord AJ,Weusten BL,Curvers WL,Timmer R,Smout AJ. Determinants of perception of heartburn and regurgitationGutYear: 20065531331816120760|
Keywords: Electric impedance, Esophageal pH Monitoring, Gastroesophageal reflux.
Previous Document: The relationship between existence of typical symptoms and psychological factors in patients with er...
Next Document: Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based ...